Profitability and cash flow
- Revenue: Not disclosed for QQ3 2025 (no revenue figure available in the quarter’s data).
- EBITDA: -$19,255.00
- Operating income: -$19,255.00
- Net income: -$10,908.00
- EPS: -$0.0001; Diluted EPS: -$0.0001
- Gross Profit: Not disclosed (grossProfit and grossProfitMargin reported as 0% in the available data).
Liquidity and cash flow
- Net cash from operating activities: -$33,038.00
- Depreciation and amortization: $1,734 (included in cash flow but not a cash outlay in this quarter’s operations)
- Change in working capital: -$23,864.00; Other working capital: -$23,864.00
- Net change in cash: $650.00; Cash at end of period: $0.95k
- Financing activities: Net cash provided by financing activities $33,772.00; Net cash used by financing activities is positive, contributing to the small net cash increase.
- Free cash flow: -$33,038.00
Balance sheet and leverage
- Total assets: $23,630.00
- Total liabilities: $2,680,521.00
- Total stockholders’ equity: -$2,656,891.00
- Cash and cash equivalents: $945.00
- Net debt: $1,827,351.00; Short-term debt: $1,817,423.00; Long-term debt: $10,873.00
- Current ratio: 0.00462; Quick ratio: 0.00462; Cash ratio: 0.000354
- Debt-to-equity: negative (due to negative equity); Debt-to-asset proxy indicates extreme leverage relative to assets.
Valuation and ratios (selected)
- Price-to-book and related equity multipliers are negative due to book value being negative; price-to-earnings and related profitability multiples are not meaningful given the ongoing losses and negative equity.
- Assets clearly insufficient to cover near-term liabilities, signaling a going-concern risk absent material balance-sheet repair or liquidity infusion.